244 related articles for article (PubMed ID: 16801631)
1. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.
Andrieu N; Easton DF; Chang-Claude J; Rookus MA; Brohet R; Cardis E; Antoniou AC; Wagner T; Simard J; Evans G; Peock S; Fricker JP; Nogues C; Van't Veer L; Van Leeuwen FE; Goldgar DE
J Clin Oncol; 2006 Jul; 24(21):3361-6. PubMed ID: 16801631
[TBL] [Abstract][Full Text] [Related]
2. Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO).
Lecarpentier J; Noguès C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Caron O; Fricker JP; Gladieff L; Faivre L; Sobol H; Gesta P; Frenay M; Luporsi E; Coupier I; ; Lidereau R; Andrieu N
Breast Cancer Res Treat; 2011 Dec; 130(3):927-38. PubMed ID: 21761160
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.
Brohet RM; Goldgar DE; Easton DF; Antoniou AC; Andrieu N; Chang-Claude J; Peock S; Eeles RA; Cook M; Chu C; Noguès C; Lasset C; Berthet P; Meijers-Heijboer H; Gerdes AM; Olsson H; Caldes T; van Leeuwen FE; Rookus MA
J Clin Oncol; 2007 Sep; 25(25):3831-6. PubMed ID: 17635951
[TBL] [Abstract][Full Text] [Related]
4. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
Pijpe A; Andrieu N; Easton DF; Kesminiene A; Cardis E; Noguès C; Gauthier-Villars M; Lasset C; Fricker JP; Peock S; Frost D; Evans DG; Eeles RA; Paterson J; Manders P; van Asperen CJ; Ausems MG; Meijers-Heijboer H; Thierry-Chef I; Hauptmann M; Goldgar D; Rookus MA; van Leeuwen FE; ; ;
BMJ; 2012 Sep; 345():e5660. PubMed ID: 22956590
[TBL] [Abstract][Full Text] [Related]
5. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
Berrington de Gonzalez A; Berg CD; Visvanathan K; Robson M
J Natl Cancer Inst; 2009 Feb; 101(3):205-9. PubMed ID: 19176458
[TBL] [Abstract][Full Text] [Related]
6. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
Andrieu N; Goldgar DE; Easton DF; Rookus M; Brohet R; Antoniou AC; Peock S; Evans G; Eccles D; Douglas F; Noguès C; Gauthier-Villars M; Chompret A; Van Leeuwen FE; Kluijt I; Benitez J; Arver B; Olah E; Chang-Claude J; ; ; ;
J Natl Cancer Inst; 2006 Apr; 98(8):535-44. PubMed ID: 16622123
[TBL] [Abstract][Full Text] [Related]
7. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Ribeiro Guerra M; Coignard J; Eon-Marchais S; Dondon MG; Le Gal D; Beauvallet J; Mebirouk N; Belotti M; Caron O; Gauthier-Villars M; Coupier I; Buecher B; Lortholary A; Fricker JP; Gesta P; Noguès C; Faivre L; Berthet P; Luporsi E; Delnatte C; Bonadona V; Maugard CM; Pujol P; Lasset C; Longy M; Bignon YJ; Adenis-Lavignasse C; Venat-Bouvet L; Dreyfus H; Gladieff L; Mortemousque I; Audebert-Bellanger S; Soubrier F; Giraud S; Lejeune-Dumoulin S; Limacher JM; Chiesa J; Fajac A; Floquet A; Eisinger F; Tinat J; Fert-Ferrer S; Colas C; Frebourg T; Damiola F; Barjhoux L; Cavaciuti E; Mazoyer S; Tardivon A; Lesueur F; Stoppa-Lyonnet D; Andrieu N
Breast Cancer Res; 2021 Aug; 23(1):79. PubMed ID: 34344426
[TBL] [Abstract][Full Text] [Related]
9. The case for individualized screening recommendations for breast cancer.
Bradbury A; Olopade OI
J Clin Oncol; 2006 Jul; 24(21):3328-30. PubMed ID: 16801629
[No Abstract] [Full Text] [Related]
10. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
Heemskerk-Gerritsen BA; Seynaeve C; van Asperen CJ; Ausems MG; Collée JM; van Doorn HC; Gomez Garcia EB; Kets CM; van Leeuwen FE; Meijers-Heijboer HE; Mourits MJ; van Os TA; Vasen HF; Verhoef S; Rookus MA; Hooning MJ;
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25788320
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.
Drooger JC; Hooning MJ; Seynaeve CM; Baaijens MH; Obdeijn IM; Sleijfer S; Jager A
Cancer Treat Rev; 2015 Feb; 41(2):187-96. PubMed ID: 25533736
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.
John EM; McGuire V; Thomas D; Haile R; Ozcelik H; Milne RL; Felberg A; West DW; Miron A; Knight JA; Terry MB; Daly M; Buys SS; Andrulis IL; Hopper JL; Southey MC; Giles GG; Apicella C; Thorne H; ; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1547-56. PubMed ID: 23853209
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
Hughes DJ; Ginolhac SM; Coupier I; Barjhoux L; Gaborieau V; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Sobol H; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Yannoukakos D; Mazoyer S; Lynch HT; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
Int J Cancer; 2005 Nov; 117(2):230-3. PubMed ID: 15900600
[TBL] [Abstract][Full Text] [Related]
15. Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).
Lecarpentier J; Noguès C; Mouret-Fourme E; Gauthier-Villars M; Lasset C; Fricker JP; Caron O; Stoppa-Lyonnet D; Berthet P; Faivre L; Bonadona V; Buecher B; Coupier I; Gladieff L; Gesta P; Eisinger F; Frénay M; Luporsi E; Lortholary A; Colas C; Dugast C; Longy M; Pujol P; Tinat J; ; Lidereau R; Andrieu N
Breast Cancer Res; 2012 Jul; 14(4):R99. PubMed ID: 22762150
[TBL] [Abstract][Full Text] [Related]
16. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
[TBL] [Abstract][Full Text] [Related]
17. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations.
Kadouri L; Hubert A; Rotenberg Y; Hamburger T; Sagi M; Nechushtan C; Abeliovich D; Peretz T
J Med Genet; 2007 Jul; 44(7):467-71. PubMed ID: 17307836
[TBL] [Abstract][Full Text] [Related]
18. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
[TBL] [Abstract][Full Text] [Related]
19. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
20. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Copson ER; Maishman TC; Tapper WJ; Cutress RI; Greville-Heygate S; Altman DG; Eccles B; Gerty S; Durcan LT; Jones L; Evans DG; Thompson AM; Pharoah P; Easton DF; Dunning AM; Hanby A; Lakhani S; Eeles R; Gilbert FJ; Hamed H; Hodgson S; Simmonds P; Stanton L; Eccles DM
Lancet Oncol; 2018 Feb; 19(2):169-180. PubMed ID: 29337092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
